Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 70  |  Page : 255-262

Neurocognitive investigation of Morinda tinctoria against amyloid beta-induced oxidative insult and cognitive impairment in albino mice: A phytotherapeutic approach


1 Department of Pharmacology and Toxicology, Centre for Laboratory Animal Technology and Research, Col. Dr. Jeppiaar Research Park, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Chennai, Tamil Nadu, India
2 Multispeciality Division, Ferring Pharmaceuticals, Saint-Prex, Switzerland
3 Department of Pharmaceutical Sciences, Mahatma Gandhi University, Kottayam, Kerala, India
4 Department of Pharmacology and Toxicology, C.L. Baid Metha College of Pharmacy, Chennai, Tamil Nadu, India

Correspondence Address:
D Sivaraman
Department of Pharmacology and Toxicology, Centre for Laboratory Animal Technology and Research, Col. Dr. Jeppiaar Research Park, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Chennai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_284_19

Rights and Permissions

Background: Alzheimer's is a progressive neurodegenerative disorder characterized by cognitive declination associated with several clinicopathological changes. Due to consistent drawback in the conventional therapy, now the attentions toward herbal therapeutics have been increased in recent times. Morinda tinctoria Roxb (MT) is a novel medicinal herb reported with versatile therapeutic activity. Still now, there is no proper scientific data available to confirm its efficacy against neurodegeneration. Objectives: The objective of the present research is to investigate the neurocognitive enhancing potential of MT against amyloid beta (Aβ) (25–35)-induced memory dysfunction in mice. Materials and Methods: Animals were pretreated with ethanol extract of MT (EEMT) and standard donepezil followed by single intracerebro ventricular injection of Aβ25–35. Estimation of antioxidant enzymes, metabolic enzymes, and neurotransmitters was performed along with quantification of inflammatory cytokines using quantitative polymerase chain reaction method. Results: The outcome of the study clearly indicates that treatment with EEMT (200 and 400 mg/kg) and donepezil (5 mg/kg) had significantly ameliorated the cognitive stress induced by Aβ25–35, which was evident from the data obtained from memory and learning task. There was a sequential decrease in pro-inflammatory cytokines such as interleukin (IL)-6, tumor necrosis factor, IL-1, and nuclear factor-κ level in EEMT and donepezil treated groups. Histological finding of the samples belonging to EEMT and donepezil treated groups reveals the presence of dense network of pyramidal cell in CA layers with increased number of granular cells aligned on the dentate gyrus zone of the hippocampi. Conclusion: Neurotherapeutics from the herbal origin advocates the potential therapeutic efficacy against Alzheimer's and may become novel entity in the clinical management of neurodegenerative diseases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed233    
    Printed4    
    Emailed0    
    PDF Downloaded50    
    Comments [Add]    

Recommend this journal